These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 33803

  • 1. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M, McKenzie JM.
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM, Zakarija M.
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [Abstract] [Full Text] [Related]

  • 5. Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue.
    Zakarija M, McKenzie JM.
    J Clin Endocrinol Metab; 1978 Oct; 47(4):906-8. PubMed ID: 95627
    [Abstract] [Full Text] [Related]

  • 6. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M.
    Horm Res; 1980 Oct; 13(1):1-15. PubMed ID: 6777285
    [Abstract] [Full Text] [Related]

  • 7. Isoelectric focusing of long-acting thyroid stimulator (LATS) containing IgG.
    Schleusener H, Adlkofer F, Uher L, Kaper-Czygan S, Kirstaedter HJ.
    Horm Metab Res; 1971 May; 3(3):221-2. PubMed ID: 5171402
    [No Abstract] [Full Text] [Related]

  • 8. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
    Szabó J, Fórizs E, Szabó T, Leövey A.
    Acta Med Hung; 1986 May; 43(3):275-81. PubMed ID: 3035480
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F, Schleusener H, Uher L, Ananos A.
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T, Kotani M, Yamada T, Ochi Y.
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract] [Full Text] [Related]

  • 13. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR, Saunders NB, Kaulfersch W, Burman KD.
    J Immunol; 1988 Apr 15; 140(8):2593-9. PubMed ID: 2895790
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR, Hall R.
    Lancet; 1974 Aug 24; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Humoral immunity in Graves' disease.
    McKenzie JM, Zakarija M, Sato A.
    Clin Endocrinol Metab; 1978 Mar 24; 7(1):31-45. PubMed ID: 580600
    [No Abstract] [Full Text] [Related]

  • 18. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS.
    J R Coll Physicians Lond; 1984 Jul 24; 18(3):155-60. PubMed ID: 6147408
    [No Abstract] [Full Text] [Related]

  • 19. The adenylate cyclase-cyclic AMP system in Graves' disease.
    Field JB, Muto H, Chou MC.
    Adv Cyclic Nucleotide Res; 1980 Jul 24; 12():359-72. PubMed ID: 6250367
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.